Reinhard Wähler

Dr. rer. nat. Reinhard Wähler

Leiter Forschung und Entwicklung der TISSO Naturprodukte GmbH
Wenden, Deutschland

Berufserfahrung

  • Tisso Naturprodukte GmbH

    10 Jahre 5 Monate

    • Head of Research & Development

      Juli 2013–Heute9 Jahre 8 Monate

      Wenden

      • Development and optimization of nutritional supplements
      • Seminars/presentations: silent inflammation, mitochondrial medicine, microbiome, nutritional strategies for health

    • Research and Development

      Okt. 2012–Heute10 Jahre 5 Monate

      Wenden, Nordrhein-Wesfalen, Germany

      www.tisso.de

  • Grant Writing

    n/a

    Feb. 2012–Mai 20124 Monate

    Berlin Area, Germany

    Gene Therapy / in vivo Stem Cell Therapy for Type 1 Diabetes

  • Research Scientist, In vivo RNAi Unit

    Cenix Bioscience

    Nov. 2008–Juli 20112 Jahre 9 Monate

    • Development and patenting of an siRNA delivery technology
    • Coordination with external companies and consultant
    • Design of chemically modified siRNA to minimize immune response
    • Heading the internal testing
    • in vivo testing of a commercial siRNA delivery technology

  • Postdoctoral Fellow

    University of Alabama at Birmingham

    Jan. 2005–Sept. 20083 Jahre 9 Monate

    • Development of a melanoma vaccine that targets dendritic cells in vivo
    • Tested promoter activity in vivo using adenoviral vectors
    • Tested the tolerable limit for replication competent adenovirus in viral preparations
    • Published review on targeted viral vectors in Nature Reviews Genetics
    • Wrote grant applications and animal protocols

  • PhD student / Postdoc

    Universitätsklinikum Hamburg Eppendorf

    2000–20044 Jahre

    • Designed, constructed and tested adenoviral vectors in vitro and in vivo
    • Developed a complex tricistronic expression cassette for cancer immunotherapy
    • Led team (surgeon, radiologist, technical staff) in preclinical testing of adenoviral vectors
    • Results led to patent and the founding of Provecs Medical

    ---
    Cancer gene therapy: Using adenoviral vectors I developed an immunostimulatory approach to enable the immune system to eliminate the tumor.
    Two tumor nodules…

  • PhD student

    Max Delbrueck Center

    Dez. 1998–Jan. 20001 Jahr 2 Monate

    Please see description under PhD student / Scientist (UKE) above.
    Initial work at the Max Delbrueck Center also included the development of a production system for gutless adenoviral vectors (a.k.a. minimal or helper-dependent adenoviral vectors). Eventually this part of my PhD work was discontinued.

  • Research Associate

    Eberhard Karls Universität Tübingen

    1997–Okt. 19981 Jahr

    Tübingen Area, Germany

    • Ribozyme technology
    • Transcription factors

  • Internship

    Bayer

    März 1995–Apr. 19952 Monate

    Wuppertal, Germany

    Bayer AG, Wuppertal, Germany
    • Cloned fibrosis related marker from mRNA library, expressed and column-purified it

    The internship was followed up by a second stay in the same laboratory as a working student in 1995.

  • Internship

    The Wistar Institute

    Sept. 1994–Dez. 19944 Monate

    Greater Philadelphia Area

    • Studied and tested ribozyme technology, learned basic molecular biology

Dieser Kurs hat Handouts

Handouts sind verfügbar für angemeldete Nutzer! Jetzt anmelden.

Artikel von Dr. rer. nat. Reinhard Wähler

Produkte von Dr. rer. nat. Reinhard Wähler

Weitere Produkte werden geladen

Simply fill out the form. You will receive the 16-page special edition immediately by e-mail free of charge.

Füllen Sie einfach das Formular aus.

Sie erhalten den Sonderdruck in wenigen Minuten per E-Mail.

Anforderung Sonderdruck Silberlinde

Füllen Sie einfach das Formular aus.

Sie erhalten den Sonderdruck in wenigen Minuten per E-Mail.

Anforderung Sonderdruck Erkältungskrankheiten

Füllen Sie einfach das Formular aus.

Sie erhalten den Sonderdruck in wenigen Minuten per E-Mail.

Sonderdruck IHHT